- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
HBA's Woman of the Year Podcast Series
Maureen Regan, managing partner of Regan Campbell Ward-McCann and the 1997 Woman of the Year, says it’s difficult to distinguish personal from professional roadblocks when you start a business.
Click Here to Listen>>>
Tamar Howson, former director of worldwide business development at SmithKline Beecham, says women must have the self-confidence to demand a life outside of the office.
Click Here to Listen>>>
Charlotte Sibley, a senior vice president for Shire, says she’s been hired, fired, upsized, downsized, promoted, demoted, and acquired-but through it all has learned some very important lessons.
Click Here to Listen>>>
In 1996, Kathy Giusti was diagnosed with a then-incurable cancer. Instead of giving up, she decided to fight back by establishing the Multiple Myeloma Research Foundation.
Click Here to Listen>>>
Meryl Zausner, CFO of Novartis North America, says that when it came to traveling for work, leaving her son was hard, but coming home was even harder.
Click Here to Listen>>>
Live life on your toes, not your heels, says Lynn O’Connor Vos, CEO of Grey Healthcare Group, and you’ll always be ready for opportunities.
Click Here to Listen>>>
Over a 30-year career, there were many bumps in the road-especially as a woman and as a minority, says Sarah Harrison, former vice president of customer strategy integration for AstraZeneca, and CEO of H&S Enterprise, Inc.
Click Here to Listen>>>
Lynn Gaudioso, president of Ivanhoe Strategies, LLC and a former vice president for Pfizer, says it’s easy to time correct for the gender issues that plagued pharma-but women need to confirm those rights.
Click Here to Listen>>>
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
